Performance analysis of IGC Pharma (IGC)
Annual Return
Over the past 3 years, IGC has had an average annual return of -0%, underperforming the benchmark SPY, which returned +22.45% annual.
Over the past 5 years, IGC has had an average annual return of -26.55%, underperforming the benchmark SPY, which returned +13.88% annual.
Over the past 10 years, IGC has had an average annual return of -4.21%, underperforming the benchmark SPY, which returned +15.45% annual.
Since Apr 13, 2006, IGC has had an average annual return of -22.82%, underperforming the benchmark SPY, which returned +11.19% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +5.88% | -16.39% | +19.61% | -12.07% | -67.23% | -37.46% | +148.25% | +123.53% | -71.82% | +254.90% | +15.91% | -63.93% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
| -35.45% | -22.86% | -53.33% | -49.71% | -58.32% | +42.33% | -83.56% | +1.03% | +5.99% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.92% | +2.04% | -4.00% | +20.83% | -10.34% | +3.85% | +5.88% | ||||||
| 2025 | -4.92% | -8.62% | -1.89% | +5.77% | +3.64% | -1.75% | +16.07% | +20% | -2.56% | -5.26% | -19.44% | -12.07% | -16.39% |
| 2024 | +3.92% | +18.87% | +15.87% | +34.25% | -10.20% | -10.23% | +5.06% | -21.69% | +18.46% | -7.79% | -5.63% | -8.96% | +19.61% |
| 2023 | +25.86% | -5.48% | -10.14% | +1.61% | -15.87% | +7.55% | +5.26% | +5% | +3.17% | -16.92% | +7.41% | -12.07% | -12.07% |
| 2022 | -1.69% | +10.34% | -10.42% | -22.09% | -41.04% | +21.52% | +0% | +6.25% | -23.53% | +2.56% | -16.25% | -13.43% | -67.23% |
| 2021 | +2.12% | +10.38% | +1.88% | -10.77% | -11.03% | +15.50% | +7.72% | -7.79% | -9.12% | -5.58% | -6.30% | -25.63% | -37.46% |
| 2020 | -0% | -29.82% | +11.25% | +10.11% | +7.14% | +3.81% | +1.83% | +96.40% | -13.30% | +5.82% | +108% | -31.97% | +148.25% |
| 2019 | +31.37% | +564.18% | -15.28% | -30.24% | -29.66% | +61.08% | -26.85% | -14.22% | -5.88% | -5.11% | -16.17% | -18.57% | +123.53% |
| 2018 | -7.73% | -25.15% | -18.40% | +2.94% | -0% | -15.24% | -12.36% | +283.33% | +291.64% | -78.91% | -44.94% | -62.50% | -71.82% |
| 2017 | -1.96% | +18% | +44.07% | -2.35% | -7.23% | -3.90% | +2.70% | -26.32% | +16.07% | +21.54% | +32.91% | +72.38% | +254.90% |
Drawdown analysis of IGC Pharma (IGC)
The maximum drawdown for the IGC was -99.77%, occurring on Nov 4, 2015. This drawdown has not yet recovered.
The current IGC drawdown is -99.50%.
Since Apr 13, 2006 IGC has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.77% | May 19, 2006 | 2382 | Nov 4, 2015 | Ongoing | Ongoing | Ongoing |
| -5.15% | Apr 18, 2006 | 20 | May 16, 2006 | 3 | May 19, 2006 | 23 |